Back to Search
Start Over
MYC gene rearrangement in diffuse large B-cell lymphoma does not confer a worse prognosis following dose-adjusted EPOCH-R.
- Source :
-
Leukemia & lymphoma [Leuk Lymphoma] 2018 Feb; Vol. 59 (2), pp. 505-508. Date of Electronic Publication: 2017 Jun 22. - Publication Year :
- 2018
- Subjects :
- Antineoplastic Combined Chemotherapy Protocols adverse effects
Cyclophosphamide adverse effects
Cyclophosphamide therapeutic use
Doxorubicin adverse effects
Doxorubicin therapeutic use
Etoposide adverse effects
Etoposide therapeutic use
Humans
Kaplan-Meier Estimate
Lymphoma, Large B-Cell, Diffuse diagnosis
Lymphoma, Large B-Cell, Diffuse mortality
Prednisone adverse effects
Prednisone therapeutic use
Rituximab administration & dosage
Treatment Outcome
Vincristine adverse effects
Vincristine therapeutic use
Antineoplastic Combined Chemotherapy Protocols therapeutic use
Gene Rearrangement
Lymphoma, Large B-Cell, Diffuse drug therapy
Lymphoma, Large B-Cell, Diffuse genetics
Proto-Oncogene Proteins c-myc genetics
Subjects
Details
- Language :
- English
- ISSN :
- 1029-2403
- Volume :
- 59
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- Leukemia & lymphoma
- Publication Type :
- Editorial & Opinion
- Accession number :
- 28641474
- Full Text :
- https://doi.org/10.1080/10428194.2017.1339882